We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
401
CBRE Group
CBRE
$40.6B
$9.96M 0.04%
248,715
-92,700
-27% -$3.83M
MTD icon
402
Mettler-Toledo International
MTD
$26.7B
$9.96M 0.04%
17,606
+1,400
+9% +$813K
ARE icon
403
Alexandria Real Estate Equities
ARE
$9.11B
$9.85M 0.04%
85,506
-14,900
-15% -$1.82M
BFAM icon
404
Bright Horizons
BFAM
$3.28B
$9.82M 0.04%
88,098
-9,635
-10% -$1.11M
FAST icon
405
Fastenal
FAST
$56.7B
$9.79M 0.04%
749,252
-61,200
-8% -$828K
JCI icon
406
Johnson Controls International
JCI
$83.8B
$9.77M 0.04%
329,532
+191,768
+139% +$6.33M
CACI icon
407
CACI
CACI
$14.1B
$9.65M 0.04%
67,000
-14,160
-17% -$2.41M
VER
408
DELISTED
VEREIT, Inc.
VER
$9.57M 0.04%
267,565
-37,960
-12% -$1.41M
BCE icon
409
BCE
BCE
$21.4B
$9.56M 0.04%
241,801
+70,200
+41% +$2.87M
LFT
410
Lument Finance Trust
LFT
$34.1M
$9.55M 0.04%
334,078
SLB icon
411
SLB Ltd
SLB
$80.4B
$9.55M 0.04%
264,623
-27,931
-10% -$1.38M
CCEP icon
412
Coca-Cola Europacific Partners
CCEP
$45.4B
$9.54M 0.04%
207,980
+63,300
+44% +$2.93M
PK icon
413
Park Hotels & Resorts
PK
$3.06B
$9.54M 0.04%
367,000
-24,600
-6% -$728K
SRPT icon
414
Sarepta Therapeutics
SRPT
$2.19B
$9.49M 0.04%
86,961
-100
-0.1% -$12.5K
D icon
415
Dominion Energy
D
$56.2B
$9.43M 0.04%
131,952
-57,947
-31% -$4.23M
CTAS icon
416
Cintas
CTAS
$79.6B
$9.39M 0.04%
223,532
-4,800
-2% -$215K
TXMD icon
417
TherapeuticsMD
TXMD
$25M
$9.27M 0.04%
48,636
+19,371
+66% +$4.72M
FL
418
DELISTED
Foot Locker
FL
$9.21M 0.04%
173,201
-197,699
-53% -$9.92M
BR icon
419
Broadridge
BR
$19.4B
$9.19M 0.04%
95,471
+31,367
+49% +$3.4M
TGNA
420
DELISTED
TEGNA Inc
TGNA
$9.14M 0.04%
840,991
-87,700
-9% -$1.06M
SWK icon
421
Stanley Black & Decker
SWK
$13.4B
$9.14M 0.04%
76,331
-324,720
-81% -$40.5M
PSA icon
422
Public Storage
PSA
$55.4B
$9.12M 0.04%
45,075
+7,486
+20% +$1.53M
KMT icon
423
Kennametal
KMT
$2.23B
$9.12M 0.04%
274,000
+1,300
+0.5% +$49.4K
CDW icon
424
CDW
CDW
$19.2B
$9.09M 0.04%
112,162
+91,500
+443% +$7.88M
FNF icon
425
Fidelity National Financial
FNF
$11.7B
$9.07M 0.04%
+299,965
New +$9.67M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.